AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | A209591 | HETERO LABS LTD UNIT V
Highest NADAC/Unit
$0.3161
per ea
Lowest NADAC/Unit
$0.2257
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 31722044830AMLODIPINE-OLMESARTAN 10-40 MG | $0.3161 | EA | Generic | — | 2026-08-19 |
| 31722044890AMLODIPINE-OLMESARTAN 10-40 MG | $0.3161 | EA | Generic | — | 2026-08-19 |
| 31722044630AMLODIPINE-OLMESARTAN 5-40 MG | $0.3122 | EA | Generic | — | 2026-08-19 |
| 31722044690AMLODIPINE-OLMESARTAN 5-40 MG | $0.3122 | EA | Generic | — | 2026-08-19 |
| 31722044730AMLODIPINE-OLMESARTAN 10-20 MG | $0.2298 | EA | Generic | — | 2026-08-19 |
| 31722044790AMLODIPINE-OLMESARTAN 10-20 MG | $0.2298 | EA | Generic | — | 2026-08-19 |
| 31722044530AMLODIPINE-OLMESARTAN 5-20 MG | $0.2257 | EA | Generic | — | 2026-08-19 |
| 31722044590AMLODIPINE-OLMESARTAN 5-20 MG | $0.2257 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.